Literature DB >> 22585726

Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis.

Tina E Faber1, Henk Groen, Martine Welfing, Koos J G Jansen, Louis J Bont.   

Abstract

Although Respiratory syncytial virus (RSV) bronchiolitis is the most important cause of hospital admission for infants during the winter season, the pathogenesis is largely unknown. Interleukin-17 (IL-17) concentrations were studied in nasopharyngeal aspirates from 21 non-ventilated and 17 ventilated infants admitted to hospital with RSV bronchiolitis at time of admission and discharge from the hospital. On admission, nasopharyngeal concentrations of most cytokines and chemokines were lower in non-ventilated infants than in ventilated infants, reaching statistical significance for Eotaxin, IL-1α, and IL-6. During course of disease, nasopharyngeal concentrations of most cytokines and chemokines decreased, reaching statistical significance for IL-6 and IP-10. However, nasopharyngeal IL-17 concentrations were higher at discharge than at admission in children with non-ventilated RSV disease (209-101 pg/ml, P = 0.008), a response pattern not observed in ventilated RSV patients nor for other cytokines or chemokines. It is speculated that local IL-17 production may be involved during convalescence from RSV bronchiolitis in non-ventilated patients by facilitating innate and adaptive antiviral immune responses. The role of IL-17 in the pathogenesis of RSV bronchiolitis is to be explored further.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585726     DOI: 10.1002/jmv.23291

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  28 in total

1.  Altered Treg and cytokine responses in RSV-infected infants.

Authors:  Allison F Christiaansen; Muhammad A Syed; Patrick P Ten Eyck; Stacey M Hartwig; Lakshmi Durairaj; Sameer S Kamath; Steven M Varga
Journal:  Pediatr Res       Date:  2016-06-21       Impact factor: 3.756

2.  Respiratory Syncytial Virus Disease Severity Is Associated with Distinct CD8+ T-Cell Profiles.

Authors:  David T Siefker; Luan Vu; Dahui You; Andrew McBride; Ryleigh Taylor; Tamekia L Jones; John DeVincenzo; Stephania A Cormier
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

Review 3.  Infant Immune Response to Respiratory Viral Infections.

Authors:  Santtu Heinonen; Rosa Rodriguez-Fernandez; Alejandro Diaz; Silvia Oliva Rodriguez-Pastor; Octavio Ramilo; Asuncion Mejias
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-15       Impact factor: 3.479

4.  Reduced Nasal Viral Load and IFN Responses in Infants with Respiratory Syncytial Virus Bronchiolitis and Respiratory Failure.

Authors:  Ryan S Thwaites; Matthew Coates; Kazuhiro Ito; Marwa Ghazaly; Calandra Feather; Farhana Abdulla; Tanushree Tunstall; Pooja Jain; Lindsey Cass; Garth Rapeport; Trevor T Hansel; Simon Nadel; Peter Openshaw
Journal:  Am J Respir Crit Care Med       Date:  2018-10-15       Impact factor: 21.405

Review 5.  Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.

Authors:  Andrea E González; Margarita K Lay; Evelyn L Jara; Janyra A Espinoza; Roberto S Gómez; Jorge Soto; Claudia A Rivera; Katia Abarca; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Virulence       Date:  2016-12-02       Impact factor: 5.882

6.  Robust Cytokine and Chemokine Response in Nasopharyngeal Secretions: Association With Decreased Severity in Children With Physician Diagnosed Bronchiolitis.

Authors:  Erin G Nicholson; Chelsea Schlegel; Roberto P Garofalo; Reena Mehta; Margaret Scheffler; Minghua Mei; Pedro A Piedra
Journal:  J Infect Dis       Date:  2016-05-18       Impact factor: 5.226

Review 7.  The role of Th17 and Treg responses in the pathogenesis of RSV infection.

Authors:  Thomas C Mangodt; Mikhaïl A Van Herck; Sara Nullens; José Ramet; Jozef J De Dooy; Philippe G Jorens; Benedicte Y De Winter
Journal:  Pediatr Res       Date:  2015-08-12       Impact factor: 3.756

8.  Cytokine responses in primary and secondary respiratory syncytial virus infections.

Authors:  Kelechi Ugonna; Konstantinos Douros; Colin D Bingle; Mark L Everard
Journal:  Pediatr Res       Date:  2016-02-16       Impact factor: 3.756

Review 9.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

10.  IL-8/IL-17 gene variations and the susceptibility to severe viral bronchiolitis.

Authors:  L A Pinto; L A DE Azeredo Leitão; M Mocellin; P Acosta; M T Caballero; R Libster; J E Vargas; F Polack; T Comaru; R T Stein; A P DE Souza
Journal:  Epidemiol Infect       Date:  2016-11-28       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.